Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445919 Zsig33-like peptides and polynucleotides
11/04/2008US7445918 Pullulanase variants and methods for preparing such variants with predetermined properties
11/04/2008US7445917 Heat-treatment to produce glycolonitrile which is converted to ammonium glycolate using enzyme catalyst having nitrilase activity; low concentrations of impurities, high yield
11/04/2008US7445915 Mutant isopropylmalate isomerase
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445904 Transgenic animal models comprising misssense mutations in gene coding cysteine string protein (CSP) for diagnosis, prevention and treatment of nervous system disorders
11/04/2008US7445901 Admixing with monoclonal antibodies; binds to ribonuclease; DNA or RNA maintains its intact, full-length form during production and storage
11/04/2008US7445900 Generating cDNA libraries via reverse transcription and polymerase amplification; gene expression and analysis
11/04/2008US7445899 Screening method for gene variation
11/04/2008US7445891 Nucleic acid triggered catalytic drug and probe release
11/04/2008US7445890 Screening for compound that inhibits uncoupling protein (Ucp) activity; measuring expression level of reporter molecule (luciferase) in transformant; drugs for obesity, diabetes, depression
11/04/2008US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445775 Mammalian nucleotide sequence coding plasminogen catalytic domain and optionally kringle domains linked to promoter; ischemic stroke, arterial thrombotic diseases
11/04/2008US7445774 Glycosylated interferon α
11/04/2008CA2486330C Stress-responsive root-specific genes
11/04/2008CA2479452C Method and device for determining analytes in a liquid
11/04/2008CA2274244C Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
11/04/2008CA2192849C Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/04/2008CA2112998C Polyphenol oxidase genes
11/02/2008CA2587198A1 Method for increasing the speed of nucleic acid amplification reactions
11/01/2008CA2627079A1 Expressing glk in plants
10/2008
10/30/2008WO2008131441A1 Methods and compositions involving ltas
10/30/2008WO2008131431A2 Modulation of blood brain barrier protein expression
10/30/2008WO2008131426A1 RIBOSOMAL PROTEIN S3: A FUNCTIONAL COMPONENT OF NF-KAPPA B p65 BINDING COMPLEXES
10/30/2008WO2008131419A2 Glycoconjugates of rna interference agents
10/30/2008WO2008131406A2 NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERp5
10/30/2008WO2008131359A1 Genetically modified biological cells
10/30/2008WO2008131230A1 Microorganism detection method and apparatus
10/30/2008WO2008131191A2 Nucleic acids hybridizable to micro rna and precursors thereof
10/30/2008WO2008131155A2 Corn plants and seed enhanced for asparagine and protein
10/30/2008WO2008131014A1 Lipopeptides and lipopeptide synthetases
10/30/2008WO2008131006A2 Method for inhibiting scavenger receptor-a and increasing immune response to antigens
10/30/2008WO2008130981A2 Methods and compositions for selecting soybean plants resistant to phytophthora root rot
10/30/2008WO2008130949A2 Modulating nurr1 expression in a cell
10/30/2008WO2008130603A2 Increased ethanol production from xylose
10/30/2008WO2008130248A1 Improvements in and relating to oil production plants
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008130034A1 Polyamino acid synthetase and gene encoding the same
10/30/2008WO2008130027A1 Improved bacterial two-hybrid assay
10/30/2008WO2008130009A1 Method for determination of progression risk of glaucoma
10/30/2008WO2008130008A1 Method for determination of onset risk of glaucoma
10/30/2008WO2008129971A1 Improved persistently infective sendai virus vector
10/30/2008WO2008129934A1 Astaxanthin-producing bacterium, bacterial culture, astaxanthin-containing composition and method of producing astaxanthin
10/30/2008WO2008129873A1 Phenylalanine aminomutase with selectivity for s-form, dna encoding the same, method for producing (s)-β-phenylalanine and method for producing (s)-β-phenylalanine analogs
10/30/2008WO2008129838A1 Germ cell marker using fish vasa gene
10/30/2008WO2008129699A1 Chimeric fusicoccane synthase and gene of the same
10/30/2008WO2008129422A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008WO2008129256A2 Hiv therapy
10/30/2008WO2008129239A2 Use of agents that inhibit homologous recombination for the treatment of cancer
10/30/2008WO2008129227A1 Improved plant oil production
10/30/2008WO2008129124A1 Novel fully human anti-vap-1 monoclonal antibodies
10/30/2008WO2008129060A2 Plant produtivity enhancement by combining chemical agents with transgenic modifications
10/30/2008WO2008128761A2 Corn having high pigment and reduced mycotoxin content, preparation and use thereof
10/30/2008WO2008128701A2 Yeast expression systems
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
10/30/2008WO2008128440A1 A series of recombinant adeno-associated viral vectors, construction methods and uses thereof
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008128293A1 Manipulation of plant senescence using modified promoters
10/30/2008WO2008128289A1 Modified plant defensin
10/30/2008WO2008112297A3 Methods of treating cancer by interfering with igf-i receptor signaling
10/30/2008WO2008110653B1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
10/30/2008WO2008109546A3 Nucleic acid compounds for inhibiting tgfbr gene expression and uses thereof
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008109516A3 Nucleic acid compounds for inhibiting ras gene expression and uses thereof
10/30/2008WO2008109381A3 Nucleic acid compounds for inhibiting hif1a gene expression and uses thereof
10/30/2008WO2008109380A3 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
10/30/2008WO2008105905A3 Methods and compositions for improved enzyme activity in transgenic plants
10/30/2008WO2008103900A3 Selection and enrichment of proteins using in vitro compartmentalization
10/30/2008WO2008101350A8 Altering carotenoid profiles in plants
10/30/2008WO2008098995A9 Genes involved in mitochondrial biogenesis
10/30/2008WO2008095027A3 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
10/30/2008WO2008093249A3 Obligate heterodimer meganucleases and uses thereof
10/30/2008WO2008092854A3 Papillomavirus e2 polypeptide used for vaccination
10/30/2008WO2008091996A3 Lettuce line p2428-5006090
10/30/2008WO2008089448A3 Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
10/30/2008WO2008088895A3 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
10/30/2008WO2008079172A3 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
10/30/2008WO2008078198A3 Cells and methodology to generate non-segmented negative-strand rna viruses
10/30/2008WO2008078177A3 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
10/30/2008WO2008073914A3 Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
10/30/2008WO2008071093A8 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10
10/30/2008WO2008068637A3 Ob-fold used as scaffold for engineering new specific binders
10/30/2008WO2008068498A3 Regulation of plant metabolism
10/30/2008WO2008067480A3 Myostatin inhibition for enhancing muscle and/or improving muscle function
10/30/2008WO2008067032A3 Transgenic mice expressing a real-time reporter for cellular camp in a tissue-selective and inducible manner
10/30/2008WO2008064056A3 Tetracycline repressor and uses thereof
10/30/2008WO2008060510A3 Zinc finger nuclease for targeting the human glucocorticoid receptor locus
10/30/2008WO2008060489A3 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals
10/30/2008WO2008059523A3 Heterologous production of interleukin 1 receptor antagonist (il-1ra) in pichia pastoris
10/30/2008WO2008057233A3 Models of erythropoiesis
10/30/2008WO2008036953A3 In vivo transformation of pancreatic acinar cells into insulin-producing cells
10/30/2008WO2008031056A3 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/30/2008WO2008024832A3 Methods for isolating and using pituitary adenoma stem cells and pituitary adenoma cells
10/30/2008WO2008017073A3 Vector systems
10/30/2008WO2008015577A3 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
1 ... 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 ... 4023